Showing 20,661 - 20,680 results of 39,386 for search '(( significant ((level disease) OR (teer decrease)) ) OR ( significant decrease decrease ))', query time: 0.72s Refine Results
  1. 20661
  2. 20662
  3. 20663
  4. 20664
  5. 20665
  6. 20666
  7. 20667
  8. 20668
  9. 20669
  10. 20670
  11. 20671

    Biological processes pathways. by Nina Germitsch (19739413)

    Published 2025
    “…A total of eight dog proteins were significantly cleaved at higher levels upon exposure to <i>A</i>. …”
  12. 20672

    Proteins with identified cleavage sites. by Nina Germitsch (19739413)

    Published 2025
    “…A total of eight dog proteins were significantly cleaved at higher levels upon exposure to <i>A</i>. …”
  13. 20673

    Data Sheet 1_Is adiponectin involved in morphea pathogenesis? – first observational study.pdf by Adriana Polańska (10823393)

    Published 2025
    “…We found no significant differences in adiponectin levels between patients with active disease and patients in the non-active phase. …”
  14. 20674
  15. 20675

    Data Sheet 1_Analysis of current status and influencing factors of participation in medication safety behaviors among older adult patients with chronic co-morbidities: based on the... by Yuxin Li (119468)

    Published 2025
    “…Multivariate linear regression analysis revealed that education level, drug concerns, disease knowledge level, health literacy, medication belief, family function, and social network were significant predictors in the regression equation (p < 0.05), accounting for 75.5% of the total variance.…”
  16. 20676

    Image 2_2′-Fucosyllactose mitigates cognitive deficits in Alzheimer models: targeting amyloid pathology, oxidative stress, and synaptic plasticity.tif by Yeasmin Akter Munni (11109630)

    Published 2025
    “…Immunohistochemical staining was used to evaluate amyloid-beta (Aβ) and phosphorylated tau (p-tau) levels in brain tissue samples. Blood samples were analyzed to determine circulating cytokine levels. …”
  17. 20677

    Image 1_2′-Fucosyllactose mitigates cognitive deficits in Alzheimer models: targeting amyloid pathology, oxidative stress, and synaptic plasticity.tif by Yeasmin Akter Munni (11109630)

    Published 2025
    “…Immunohistochemical staining was used to evaluate amyloid-beta (Aβ) and phosphorylated tau (p-tau) levels in brain tissue samples. Blood samples were analyzed to determine circulating cytokine levels. …”
  18. 20678
  19. 20679

    Image 2_Development and validation of nomograms based on pre-/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resectio... by Xuan Dai (5153786)

    Published 2024
    “…The objective of this research is to develop clinical prediction models based on preoperative and postoperative CEA and CA19-9 levels.</p>Methods<p>1,452 consecutive participants with stage I-III colorectal cancer were included. …”
  20. 20680

    Image 1_Development and validation of nomograms based on pre-/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resectio... by Xuan Dai (5153786)

    Published 2024
    “…The objective of this research is to develop clinical prediction models based on preoperative and postoperative CEA and CA19-9 levels.</p>Methods<p>1,452 consecutive participants with stage I-III colorectal cancer were included. …”